Recce Pharmaceuticals Ltd
ASX:RCE

Watchlist Manager
Recce Pharmaceuticals Ltd Logo
Recce Pharmaceuticals Ltd
ASX:RCE
Watchlist
Price: 0.455 AUD -5.21% Market Closed
Market Cap: 105.5m AUD
Have any thoughts about
Recce Pharmaceuticals Ltd?
Write Note

P/E
Price to Earnings

-6
Current
-10.9
Median
22.1
Industry
Higher than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-6
=
Market Cap
105.5m AUD
/
Net Income
-17.7m AUD
All Countries
All Countries
Close
Earnings Growth P/E to Growth
AU
Recce Pharmaceuticals Ltd
ASX:RCE
Average P/E: 33.1
Negative Multiple: -6 		N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
88.4
451%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35.7
86%
0.4
US
Johnson & Johnson
NYSE:JNJ
24
-22%
N/A
US
Merck & Co Inc
NYSE:MRK
20.9
7 314%
0
CH
Roche Holding AG
SIX:ROG
17.8
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
32
177%
0.2
CH
Novartis AG
SIX:NOVN
11
31%
0.4
US
Pfizer Inc
NYSE:PFE
35.2
733%
0

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-6.4
2-Years Forward
P/E
-1.3
3-Years Forward
P/E
N/A

See Also

Summary
RCE intrinsic value, competitors valuation, and company profile.
DCF Valuation
RCE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RCE stock valuation using valuation multiples.
Wall Street Estimates
RCE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RCE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 209,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.